Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1980 Jul;44(1):96–100. doi: 10.1136/hrt.44.1.96

Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.

N S Baber, D W Evans, G Howitt, M Thomas, T Wilson, J A Lewis, P M Dawes, K Handler, R Tuson
PMCID: PMC482366  PMID: 7000100

Abstract

A multicentre study of survivors of an anterior myocardial infarction is reported. The trial consisted of 720 patients and was a double-blind, placebo-controlled study with propranolol 40 mg three times a day. Trial entry was at two to 14 days (mean 8.5 days) and follow-up at one, three, and in most centres, six and nine months. The trial was designed to detect a 50 per cent reduction in mortality and this was not shown. The non-fatal reinfarction rate was similar in both groups. Subgroup analysis identified several prognostic risk factors for death, none of which interacted with treatment.

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlmark G., Saetre H., Korsgren M. Letter: Reduction of sudden Deaths after myocardial infarction. Lancet. 1974 Dec 28;2(7896):1563–1563. doi: 10.1016/s0140-6736(74)90299-2. [DOI] [PubMed] [Google Scholar]
  2. Barber J. M., Boyle D. M., Chaturvedi N. C., Singh N., Walsh M. J. Practolol in acute myocardial infarction. Acta Med Scand Suppl. 1976;587:213–219. doi: 10.1111/j.0954-6820.1976.tb05884.x. [DOI] [PubMed] [Google Scholar]
  3. Bodem G., Chidsey C. A. Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26–29. doi: 10.1002/cpt197314126. [DOI] [PubMed] [Google Scholar]
  4. Carruthers S. G., Kelly J. G., McDevitt D. G., Shanks R. G. Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther. 1974 May;15(5):497–509. doi: 10.1002/cpt1974155497. [DOI] [PubMed] [Google Scholar]
  5. Clausen J., Felsby M., Jorgensen F. S., Nielsen B. L., Roin J., Strange B. Absence of prophylactic effect of propranolol in myocardial infarction. Lancet. 1966 Oct 29;2(7470):920–924. doi: 10.1016/s0140-6736(66)90533-2. [DOI] [PubMed] [Google Scholar]
  6. Freiman J. A., Chalmers T. C., Smith H., Jr, Kuebler R. R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978 Sep 28;299(13):690–694. doi: 10.1056/NEJM197809282991304. [DOI] [PubMed] [Google Scholar]
  7. Norris R. M., Caughey D. E., Scott P. J. Trial of propranolol in acute myocardial infarction. Br Med J. 1968 May 18;2(5602):398–400. doi: 10.1136/bmj.2.5602.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Norris R. M., Clarke E. D., Sammel N. L., Smith W. M., Williams B. Protective effect of propranolol in threatened myocardial infarction. Lancet. 1978 Oct 28;2(8096):907–909. doi: 10.1016/s0140-6736(78)91628-8. [DOI] [PubMed] [Google Scholar]
  9. Reynolds J. L., Whitlock R. M. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset. Br Heart J. 1972 Mar;34(3):252–259. doi: 10.1136/hrt.34.3.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rose G. Population screening for myocardial ischemia. Am Heart J. 1978 Oct;96(4):427–429. doi: 10.1016/0002-8703(78)90150-3. [DOI] [PubMed] [Google Scholar]
  11. Sloman G., Stannard M. Beta-adrenergic blockade and cardiac arrhythmias. Br Med J. 1967 Dec 2;4(5578):508–512. doi: 10.1136/bmj.4.5578.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Snow P. J. Effect of propranolol in myocardial infarction. Lancet. 1965 Sep 18;2(7412):551–553. doi: 10.1016/s0140-6736(65)90863-9. [DOI] [PubMed] [Google Scholar]
  13. Sowton E. Beta-adrenergic blockade in cardiac infarction. Prog Cardiovasc Dis. 1968 May;10(6):561–572. doi: 10.1016/0033-0620(68)90006-6. [DOI] [PubMed] [Google Scholar]
  14. Wilhelmsson C., Vedin J. A., Wilhelmsen L., Tibblin G., Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. doi: 10.1016/s0140-6736(74)90807-1. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES